CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
December 2019—Ortho Clinical Diagnostics, in collaboration with Thermo Fisher Scientific, has expanded the menu on MicroTip-capable Vitros systems to enable testing for fentanyl and tricyclic antidepressants.
The DRI Fentanyl Assay has a sensitivity of 100 percent and cross-reacts with various analogs of fentanyl. It is available in the U.S. for criminal justice and forensic use only. It is not intended for clinical diagnosis of disease or other conditions, including a determination of the state of health, in order to cure, mitigate, treat, or prevent disease or its sequelae or patient management. The 510(k)-cleared DRI Tricyclics Serum Tox Assay can help clinicians detect the use of tricyclic antidepressants in potential overdose victims.
Pages: 1 2